Pfizer Completes Acquisition of NextWave Pharmaceuticals

Pfizer (NYSE: PFE  ) today announced the completion of its acquisition of privately held NextWave Pharmaceuticals, which focuses its drug research and development efforts on products designed to treat attention deficit hyperactivity disorder (ADHD).

After closing the acquisition, Pfizer now holds the exclusive North American rights to distribute Quillivant XR, the first once-daily liquid medication approved by the FDA to treat ADHD. According to Pfizer's press release, Quillivant XR is expected to be available in pharmacies in January, after receiving FDA approval in September.

Pfizer announced its intention to acquire NextWave Pharma in October, saying it would pay $255 million to NextWave's shareholders at the closing of the transaction and up to $425 million if certain sales milestones are reached. Pfizer made a $20 million option payment to NextWave in the second quarter of this year.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2130900, ~/Articles/ArticleHandler.aspx, 9/18/2014 3:45:56 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement